Virtual Screening and Discovery of Matrix Metalloproteinase‐12 Inhibitors by Swarm Intelligence Optimization Algorithm‐Based Machine Learning

[1]  S Gordon,et al.  Elastase secretion by stimulated macrophages. Characterization and regulation , 1975, The Journal of experimental medicine.

[2]  Hajime Mishima,et al.  Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[3]  V. Yong,et al.  Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. , 2006, Cancer research.

[4]  S. Shapiro,et al.  Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. , 1999, The Journal of investigative dermatology.

[5]  Satya P. Gupta.  Matrix Metalloproteinase Inhibitors , 2012, Experientia Supplementum.

[6]  T Kobayashi,et al.  Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development. , 1998, The American journal of pathology.

[7]  J. Klopfenstein,et al.  MMP-12, a Promising Therapeutic Target for Neurological Diseases , 2017, Molecular Neurobiology.

[8]  J. Klopfenstein,et al.  Matrix Metalloproteinase-12 Induces Blood–Brain Barrier Damage After Focal Cerebral Ischemia , 2015, Stroke.

[9]  Günther Richter,et al.  Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  Helga E. de Vries,et al.  Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions , 2003, Journal of Neuroimmunology.

[11]  Min Yang,et al.  Prediction of matrix metal proteinases-12 inhibitors by machine learning approaches , 2018, Journal of biomolecular structure & dynamics.

[12]  I. Narita,et al.  Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis 1 , 2003, The Journal of Immunology.

[13]  H. Nar,et al.  Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor. , 2001, Journal of molecular biology.

[14]  M. Cher,et al.  Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP‐12 dependent manner , 2008, International journal of cancer.

[15]  Bernard Pirard,et al.  Insight into the structural determinants for selective inhibition of matrix metalloproteinases. , 2007, Drug discovery today.

[16]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[17]  Philippe Cuniasse,et al.  Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12* , 2006, Journal of Biological Chemistry.

[18]  Dimitris Georgiadis,et al.  Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S1′ Loop Canonical Conformation* , 2010, The Journal of Biological Chemistry.

[19]  Pierre Ducrot,et al.  Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors. , 2005, Bioorganic & medicinal chemistry letters.

[20]  Jason L. Johnson,et al.  Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Wei Li,et al.  A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408). , 2009, Journal of medicinal chemistry.

[22]  Jeff Biernaskie,et al.  Matrix metalloproteinase (MMP)‐12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice , 2005, The European journal of neuroscience.

[23]  T. Ley,et al.  Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. , 1993, The Journal of biological chemistry.

[24]  V. Lagente,et al.  Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease , 2004, Inflammation Research.

[25]  Jamal Shamsara,et al.  Receptor-based 3D-QSAR approach to find selectivity features of flexible similar binding sites: case study on MMP-12/MMP-13 , 2015, Int. J. Bioinform. Res. Appl..

[26]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[27]  Yingyan Yu,et al.  Increase in the expression of matrix metalloproteinase-12 in the airways of rats with allergic bronchial asthma. , 2007, Biological & pharmaceutical bulletin.

[28]  C. Le Quément,et al.  Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases , 2009 .

[29]  A. Gearing,et al.  Design and therapeutic application of matrix metalloproteinase inhibitors. , 1999, Chemical reviews.

[30]  Gregg B Fields,et al.  Potential clinical implications of recent matrix metalloproteinase inhibitor design strategies , 2015, Expert review of proteomics.

[31]  Gaurao V. Dhoke,et al.  3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors , 2013 .

[32]  Francisco Martínez-Murillo,et al.  MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis. , 2009, Rheumatology.

[33]  Enqi Liu,et al.  Macrophage Metalloelastase Accelerates the Progression of Atherosclerosis in Transgenic Rabbits , 2006, Circulation.

[34]  H. Friess,et al.  Human Macrophage Metalloelastase Worsens the Prognosis of Pancreatic Cancer , 2002, Annals of surgery.

[35]  Armando Rossello,et al.  Sugar‐Based Arylsulfonamide Carboxylates as Selective and Water‐Soluble Matrix Metalloproteinase‐12 Inhibitors , 2016, ChemMedChem.

[36]  S. Shapiro,et al.  Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. , 2000, The Journal of investigative dermatology.

[37]  Sophie Perrier,et al.  Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12. , 2004, Journal of molecular biology.

[38]  V. Wee Yong,et al.  An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice , 2003, The Journal of Neuroscience.

[39]  F. Beau,et al.  A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E–Knockout Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[40]  Yutaka Shimada,et al.  Clinicopathological Significance of Human Macrophage Metalloelastase Expression in Esophageal Squamous Cell Carcinoma , 2002, Oncology.

[41]  Mark D. Huffman,et al.  Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. , 1998, The Journal of clinical investigation.

[42]  Kazunari Yoshizawa,et al.  A QSAR study on the inhibition mechanism of matrix metalloproteinase-12 by arylsulfone analogs based on molecular orbital calculations. , 2015, Organic & biomolecular chemistry.

[43]  Benjamin Fabre,et al.  Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors. , 2014, Journal of medicinal chemistry.

[44]  Dimitris Georgiadis,et al.  Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity. , 2010, Biochimie.